GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XBiotech Inc (STU:4XB) » Definitions » Price-to-Funds-From-Operations

XBiotech (STU:4XB) Price-to-Funds-From-Operations : (As of Apr. 10, 2025)


View and export this data going back to 2015. Start your Free Trial

What is XBiotech Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


XBiotech Business Description

Industry
Traded in Other Exchanges
Address
5217 Winnebago Lane, Austin, TX, USA, 78744
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.